Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation: A Multicenter, Randomized Controlled Trial

NCT07277907 is registered in ClinicalTrials.gov with Third Military Medical University as lead sponsor.

NCT NCT07277907
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07277907 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Lubiprostone in the Treatment of Slow Transit Constipation: A Multicenter, Randomized Controlled Trial
Lead sponsor
Third Military Medical University
Phase
Phase 3
Overall status
Recruiting
Start date
November 13, 2025
Completion date
November 30, 2027
Enrollment
346 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

pharmacotherapy, slow transit constipation